Package 70842-225-01

Brand: kimyrsa

Generic: oritavancin diphosphate
NDC Package

Package Facts

Identity

Package NDC 70842-225-01
Digits Only 7084222501
Product NDC 70842-225
Product ID 70842-225_25ae2ae5-afce-4475-bf3c-45323e93a952
Description

1 VIAL in 1 CARTON (70842-225-01) / 40 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2021-03-23
Brand kimyrsa
Generic oritavancin diphosphate
Sample Package No

Linked Drug Pages (1)

Kimyrsa ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "25ae2ae5-afce-4475-bf3c-45323e93a952", "openfda": {"upc": ["0370842225016"], "unii": ["VL1P93MKZN"], "rxcui": ["2532361", "2532366"], "spl_set_id": ["5e755c40-6e73-4572-b474-4d8a131693d1"], "manufacturer_name": ["Melinta Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (70842-225-01)  / 40 mL in 1 VIAL", "package_ndc": "70842-225-01", "marketing_start_date": "20210323"}], "brand_name": "Kimyrsa", "product_id": "70842-225_25ae2ae5-afce-4475-bf3c-45323e93a952", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Lipoglycopeptide Antibacterial [EPC]", "Lipoglycopeptides [CS]"], "product_ndc": "70842-225", "generic_name": "oritavancin diphosphate", "labeler_name": "Melinta Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Kimyrsa", "active_ingredients": [{"name": "ORITAVANCIN DIPHOSPHATE", "strength": "1200 mg/40mL"}], "application_number": "NDA214155", "marketing_category": "NDA", "marketing_start_date": "20210323", "listing_expiration_date": "20261231"}